Lee TH, Lee H, Jang JY, Park W, et al. Refined risk stratification in residual triple-negative breast cancer after
neoadjuvant therapy using residual cancer burden class and lymphovascular
invasion. Breast Cancer Res Treat 2026;215:76.
PMID: 41642482
|